Itopride (INN) is a prokinetic benzamide derivative unlike metoclopramide or domperidone.
These drugs inhibit dopamine and have a gastrokinetic effect.
Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions.
Itopride is not currently approved by the U.S. Food and Drug Administration (FDA) for use in the United States, nor is it yet approved in the United Kingdom.
|Itopride Pellets Systematic (IUPAC) Name||Itopride Pellets Identifiers||Itopride Pellets Chemical data|
We supply Itopride in pellets form and granules form. Our Itopride Pellets can be used in a variety of Pharmaceutical applications like It can be used in tablets and capsules.
We also offer Sustained Release(SR) / Immediate Release (IR) and Enteric Coated (EC) Itopride Pellets.
Umang pharmatech has the capability to manufacture Itopride Pellets of various particle sizes.